A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
Clinical trial NCT03226899 · TERMINATED
Trial details
- NCT number
- NCT03226899
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2019-02-25
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.